Different mechanisms contribute to the biphasic pattern of carboxypeptidase U (TAFla) generation during in vitro clot lysis in human plasma

被引:43
作者
Leurs, J
Wissing, BM
Nerme, V
Schatteman, K
Björquist, P
Hendriks, D [1 ]
机构
[1] Univ Antwerp, Med Biochem Lab, Antwerp, Belgium
[2] AstraZeneca R&D, Dept Cell Biol & Biochem, Molndal, Sweden
[3] AstraZeneca R&D, Dept Integrat Pharmacol, Molndal, Sweden
关键词
carboxypeptidase U; TAFI; clot lysis; inogatran; fibrinolysis;
D O I
10.1055/s-0037-1613441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Carboxypeptidase U (CPU, TAFla) recently gained interest as a significant player in dampening the fibrinolytic rate. The aim of this study was to investigate the time course of the generation of CPU activity during coagulation and fibrinolysis using an in vitro clot lysis model in human plasma. A first peak of CPU activity appeared after initiation of the coagulation phase and a second rise in CPU activity was observed during the fibrinolysis. The decrease in the proCPU plasma concentration followed the same trend as the appearance of the CPU activity. The direct thrombin inhibitor inogatran eliminated the CPU generation during coagulation but not during fibrinolysis. Addition of the plasmin inhibitor aprotinin during fibrinolysis resulted in a decrease in CPU activation during the lysis phase. These results demonstrate that proCPU was activated during coagulation by thrombin and during fibrinolysis by plasmin. Addition of a CPU inhibitor before initiation of clotting decreased the clot lysis time as expected. However, addition in the time period between the two peaks of CPU activity had no apparent effect on the clot lysis time.
引用
收藏
页码:264 / 271
页数:8
相关论文
共 35 条
[1]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[2]   PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR [J].
BAJZAR, L ;
MANUEL, R ;
NESHEIM, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14477-14484
[3]   Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor [J].
Bajzar, L ;
Nesheim, M ;
Morser, J ;
Tracy, PB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (05) :2792-2798
[4]   The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent [J].
Bajzar, L ;
Nesheim, ME ;
Tracy, PB .
BLOOD, 1996, 88 (06) :2093-2100
[5]   Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor [J].
Boffa, MB ;
Bell, R ;
Stevens, WK ;
Nesheim, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (17) :12868-12878
[6]   Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma [J].
Broze, GJ ;
Higuchi, DA .
BLOOD, 1996, 88 (10) :3815-3823
[8]  
EATON DL, 1991, J BIOL CHEM, V266, P21833
[9]  
ESMON NL, 1982, J BIOL CHEM, V257, P859
[10]   CHARACTERIZATION OF THE BINDING OF PLASMINOGEN TO FIBRIN SURFACES - THE ROLE OF CARBOXY-TERMINAL LYSINES [J].
FLEURY, V ;
ANGLESCANO, E .
BIOCHEMISTRY, 1991, 30 (30) :7630-7638